Proceedings of 31st AGM of the Company
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Parmax Pharma Limited held its 31st Annual General Meeting on September 30, 2025, at its registered office in Rajkot, Gujarat, from 3:30 PM to 3:54 PM. Mr. Umang Gosalia, Managing Director, chaired the meeting. Three ordinary resolutions were put to vote: (1) adoption of audited financial statements for FY ended March 31, 2025, (2) re-appointment of Mr. Umang Alkesh Gosalia as Director (retiring by rotation), and (3) appointment of Mr. Samsad Alam Khan as Secretarial Auditor. CFO Mr. Keyur Vora briefed members on the company's financial performance for the year ended March 31, 2025. E-voting was conducted via the NSDL platform, and shareholders present were also allowed to vote via ballot paper.
This is a routine, procedural AGM filing with no major corporate actions or surprises. All resolutions are standard items — financial statement approval, director re-appointment, and auditor appointment. No specific financial numbers were disclosed in the proceedings. Neutral to marginally positive signal for shareholders, confirming the company is meeting its compliance obligations.